Asset Details
MbrlCatalogueTitleDetail
Do you wish to reserve the book?
GM-CSF-based treatments in COVID-19: reconciling opposing therapeutic approaches
by
Lang, Frederick M
, Becher Burkhard
, Hamilton, John A
, Lee, Kevin M-C
, Teijaro, John R
in
Alveoli
/ Clinical trials
/ Colonies
/ Colony-stimulating factor
/ Coronaviridae
/ Coronaviruses
/ COVID-19
/ Granulocyte-macrophage colony-stimulating factor
/ Granulocytes
/ Homeostasis
/ Immunological diseases
/ Inflammation
/ Lung diseases
2020
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
You are currently in the queue to collect this book. You will be notified once it is your turn to collect the book.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
GM-CSF-based treatments in COVID-19: reconciling opposing therapeutic approaches
by
Lang, Frederick M
, Becher Burkhard
, Hamilton, John A
, Lee, Kevin M-C
, Teijaro, John R
in
Alveoli
/ Clinical trials
/ Colonies
/ Colony-stimulating factor
/ Coronaviridae
/ Coronaviruses
/ COVID-19
/ Granulocyte-macrophage colony-stimulating factor
/ Granulocytes
/ Homeostasis
/ Immunological diseases
/ Inflammation
/ Lung diseases
2020
Oops! Something went wrong.
While trying to remove the title from your shelf something went wrong :( Kindly try again later!
Do you wish to request the book?
GM-CSF-based treatments in COVID-19: reconciling opposing therapeutic approaches
by
Lang, Frederick M
, Becher Burkhard
, Hamilton, John A
, Lee, Kevin M-C
, Teijaro, John R
in
Alveoli
/ Clinical trials
/ Colonies
/ Colony-stimulating factor
/ Coronaviridae
/ Coronaviruses
/ COVID-19
/ Granulocyte-macrophage colony-stimulating factor
/ Granulocytes
/ Homeostasis
/ Immunological diseases
/ Inflammation
/ Lung diseases
2020
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
GM-CSF-based treatments in COVID-19: reconciling opposing therapeutic approaches
Journal Article
GM-CSF-based treatments in COVID-19: reconciling opposing therapeutic approaches
2020
Request Book From Autostore
and Choose the Collection Method
Overview
Therapeutics against coronavirus disease 2019 (COVID-19) are urgently needed. Granulocyte–macrophage colony-stimulating factor (GM-CSF), a myelopoietic growth factor and pro-inflammatory cytokine, plays a critical role in alveolar macrophage homeostasis, lung inflammation and immunological disease. Both administration and inhibition of GM-CSF are currently being therapeutically tested in COVID-19 clinical trials. This Perspective discusses the pleiotropic biology of GM-CSF and the scientific merits behind these contrasting approaches.Recombinant granulocyte–macrophage colony-stimulating factor (GM-CSF) as well as antibodies targeted at GM-CSF or its receptor are being tested in clinical trials for coronavirus disease 2019 (COVID-19). This Perspective introduces the pleiotropic functions of GM-CSF and explores the rationale behind these different approaches.
Publisher
Nature Publishing Group
This website uses cookies to ensure you get the best experience on our website.